The Department/Division of Population Sciences – Outcomes Research within the Beckman Research Institute of City of Hope invites applications from qualified individuals for a Professor Series faculty position. Recruitment will be at the full Professor level. The individual will be a NIH R01 funded full professor (or equivalent) with a national reputation for pharmacokinetics and pharmacogenetics. Expertise in hematologic malignancies and transplantation drug modeling and survivorship is required. The individual must also have an interest in precision medicine in diverse populations. Candidates at the professor level will have established an internationally recognized research program with a strong track record in extramural peer reviewed funding and high impact publications. A competitive start-up package including faculty salary and research support will be provided commensurate with experience. Review of the completed applications will begin immediately and continue until the position is filled. A start date in the 2016-2017 academic year is anticipated. Further information about the department and division can be found on the department website:

A Ph.D. PharmD or MD/DO degree is required for this position as well as a fluency in spoken and written English. A pplications must include 1) curriculum vitae, listing publications and extramural funding history; 2) brief (2 pages max) statement of research interests; 3) names of three referees who will be sent requests for letters of recommendation. Applications and supporting materials should be addressed to: The Department/Division of Population Sciences – Outcomes Research and sent c/o [email protected]

About City of Hope

City of Hope, an innovative biomedical research, treatment and educational institution with over 4000 employees, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate, patient-centered philosophy. Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment.

City of Hope is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, or status as a qualified individual with disability.

Back to top